CUAMC
China Universal Asset Management Company’s Apogee Therapeutics APGE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $619K | Buy |
14,248
+5,216
| +58% | +$227K | 0.06% | 225 |
|
|
2025
Q1 | $337K | Sell |
9,032
-515
| -5% | -$19.2K | 0.03% | 275 |
|
|
2024
Q4 | $432K | Buy |
9,547
+892
| +10% | +$40.4K | 0.04% | 263 |
|
|
2024
Q3 | $508K | Buy |
8,655
+3,371
| +64% | +$198K | 0.06% | 216 |
|
|
2024
Q2 | $208K | Sell |
5,284
-1,871
| -26% | -$73.6K | 0.03% | 238 |
|
|
2024
Q1 | $475K | Buy |
7,155
+1,600
| +29% | +$106K | 0.06% | 185 |
|
|
2023
Q4 | $155K | Buy |
+5,555
| New | +$155K | 0.03% | 232 |
|